Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

+44 1300 500008

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

59 57 32 59 77 13 11 20 37 22 37 55 22 12

Research, Review articles and Editorials

1 0 5 42 32 12 10 14 27 21 33 44 21 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

48 57 27 17 45 1 1 6 10 1 4 11 1 2

Conference proceedings

0 0 0 0 0 0 35 51 125 100 191 0 125 177

Citations received as per Google Scholar, other indexing platforms and portals

98 160 172 269 223 172 219 195 170 116 60 36 26 58
Journal total citations count 2004
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2019 17
Important citations (1101)

wisskirchen k, kah j, malo a, asen t, volz t, allweiss l, et al. t cell receptor grafting allows virological control of hepatitis b virus infection. the j clin invest. 2019; 30; 129(7):2932-2945.

santos bs. avaliação de modelos murinos utilizando camundongos imunocompetentes e vírus não adaptados para o estudo da dengue (doctoral dissertation).

srilatha b. a review on gene cloning and genome organization. biochem mol biol lett. 2017;3(2):122.

paladugula d. a review on computational drug designing and discovery. biochem mol biol lett. 2017; 3(2):1.

dolma k. zika virus (zikv) infection: a review. j res development. 2016;4(148):2.

arjanova ov, prihoda nd, yurchenko lv, sokolenko ni, frolov vm. phase 2 trial of v-5 immunitor (v5) in patients with chronic hepatitis c co-infected with hiv and mycobacterium tuberculosis. j vaccines vaccin. 2010;1: 103.

himabindu a, soumya d. incidence of diabetes and its control measures in aids patients. j diabetes metab. 2011;2(169):2.

ndarabu wm, mulumba p, mbuyi d, tshilolo l. trial of immunotherapy in hiv patients: our experience with the immuno-modulator dithiodinicotinic acid (cpds) in 34 congolese patients. global journal of medical research. 2017.

igulu an, muepu lt, mukendi dm, goldfarb rh. clinical and biological outcomes in an hiv-positive child treated with the immuno-modulator 6, 6’-dithiodinicotinic acid (cpds) over four years: a case report.

himabindu a, soumya d. incidence of diabetes and its control measures in aids patients. j diabetes metab. 2011;2(169):2.

vanita p, jhansi k. metabolic syndrome in endocrine system. j diabetes metab. 2011;2(163):2.

himabindu a, soumya d. incidence of diabetes and its control measures in aids patients. j diabetes metab. 2011;2(169):2.

arun kr, sathish kd, nishanth t. assessment & effectiveness of surgeries in human safety. j clinic experiment ophthalmol. 2011;2(201): 2.

arun kr, sathish kd, nishanth t. a confront on cancer allied diabetic patients. j carcinogene mutagene. 2011;2(126):22-4.

rosen rb, bora ns, young rs, singh k, bora ps, chan jw, et al. journal of clinical & experimental ophthalmology.

jeevani t. opportunistic infections of aids and their effects on humans. j aids clinic res. 2011;2(132): 2.

pradegan n, rossi e, gerosa g, bottio t. diagnostic ‘nightmares’ in an hiv patient with a cardiac mass and a previous history of tuberculosis. j cardiovasc med (hagerstown). 2019;20(12):841-843.

perdana am, saintika m. seorang pasien aids dengan efusi perikard masif. 2018;14(1):25-31.

himabindu a, soumya d. incidence of diabetes and its control measures in aids patients. j diabetes metab. 2011;2(169):2.

reed l (2016) evaluation of pro-inflammatory cytokines expression in mouse splenocytes after incubation with biofield treated herbomineral formulation: effect of biofield energy healing treatment-the trivedi effect®. american journal of biomedical and life sciences 4: 87-97.

Top